Renoprotective effects of dapagliflozin in diabetic patients with chronic kidney disease: A retrospective observational study
The use of dapagliflozin was associated with significant renal protection and lower hospitalizations without compromising patient safety. These findings support the beneficial role of dapagliflozin in preserving renal function in this high-risk population.
Authors
- Aly M. Abdelrahman (ORCID: https://orcid.org/0000-0002-7959-1784)
- Raya Al Maskari
- Sara Fahad Dawood Al Lawati (ORCID: https://orcid.org/0009-0000-7513-014X)
- Juhaina Al Maqbali
Institutions
- Sultan Qaboos University (OM)
Publication Details
- Journal
- British Journal of Clinical Pharmacology
- Published
- 2026-02-03
- DOI
- https://doi.org/10.1002/bcp.70458
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00